SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001171843-24-007041
Filing Date
2024-12-20
Accepted
2024-12-20 16:40:44
Documents
16
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A edsa20240930_10ka.htm   iXBRL 10-K/A 186944
2 EXHIBIT 31.3 ex_758888.htm EX-31.3 4235
3 EXHIBIT 31.4 ex_758889.htm EX-31.4 4231
  Complete submission text file 0001171843-24-007041.txt   406382

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA edsa-20240930.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20240930_def.xml EX-101.DEF 16338
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20240930_lab.xml EX-101.LAB 22264
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20240930_pre.xml EX-101.PRE 17213
19 EXTRACTED XBRL INSTANCE DOCUMENT edsa20240930_10ka_htm.xml XML 6983
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-37619 | Film No.: 241568522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)